
Bripca 10mg Injection
Marketer
Ipca Laboratories Ltd
Salt Composition
Brivaracetam (10mg)
Overview Bripca 10mg Injection
Levetiracetam 10mg Injection is an anticonvulsant medication prescribed to manage epileptic seizures. It's suitable as monotherapy for adults or in combination with other medications for adults and children. Its seizure-preventative effects persist with continued use, as it reduces abnormal brain electrical activity. Administer with or without food, ideally at the same time daily for optimal efficacy. Dosage is individualized based on patient response and condition, determined by your physician. Generally, it's a long-term treatment; discontinuation should only occur under medical supervision, as premature cessation or missed doses can exacerbate seizures. Gradual withdrawal over several months is recommended. Switching brands requires doctor approval. Maintain a consistent supply. Although serious adverse events are rare, common side effects include somnolence, anorexia, abdominal discomfort, and diarrhea. Behavioral changes (aggression), depression, insomnia, vertigo, balance issues, and skin rashes may also occur. These are often more pronounced initially, diminishing with continued use. While most side effects are mild, some require medical attention. Report any symptoms to your doctor; management strategies may be available. Suicidal ideation has been reported in a small percentage of patients; consult your physician if you experience mood deterioration. Prior to commencing treatment, disclose any renal impairment, pre-existing depression or suicidal tendencies, and pregnancy status (or pregnancy plans). Breastfeeding is contraindicated. Alcohol consumption increases seizure risk and intensifies side effects like drowsiness and dizziness; avoid alcohol during treatment. Impaired alertness (drowsiness/dizziness) may compromise driving or operating machinery. Regular kidney function monitoring is often necessary.
Uses of Bripca 10mg Injection
Convulsive disorders
Major Benefits of Bripca 10mg Injection:
Administering this medication will be handled by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Bripca 10mg Injection:
- Dizziness
- Sedation
- Drowsiness
- Neuropsychiatric symptoms
How to use Bripca 10mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Bripca 10mg Injection works:
Bripca 10mg Injection, an anticonvulsant, acts by binding to SV2A receptors located on neuronal membranes. This binding action reduces aberrant neuronal firing in the brain, thereby preventing the propagation of seizure-inducing electrical impulses.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while using Bripca 10mg Injection is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Bripca 10mg Injection during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the use of Bripca 10mg Injection while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
The administration of Bripca 10mg Injection can lead to reduced awareness, visual disturbances, drowsiness, and dizziness. Driving should be avoided if any of these effects are experienced.
KidneySAFE IF PRESCRIBED
Bripca 10mg Injection poses no safety concerns for individuals with kidney impairment; dosage modification is unnecessary. However, Brivaracetam should be avoided in patients with end-stage renal disease due to a lack of supporting clinical evidence.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Bripca 10mg Injection; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Bripca 10mg Injection :
NA
Facts to Know About Bripca 10mg Injection
| Label | Value |
|---|---|
| Chemical Type | Levetiracetam Analog |
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
| Action Category | AED: A protein ligand within synaptic vesicle 2 |
